Classification-Index

Classification 2025 Summer Edition

Worldwide source of medical classification resources

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Class Index

← Previous

...

Muscarinic Effects See Cholinergic Agents

Muscarinic Receptor See Receptors, Muscarinic

Muscarinic Receptors See Receptors, Muscarinic

Muscarinics See Cholinergic Agents

Musci See Bryophyta

Muscimol Receptor See Receptors, GABA-A

Muscimol Receptors See Receptors, GABA-A

Muscle Cancer See Muscle Neoplasms

Muscle Cells, Cardiac See Myocytes, Cardiac

Muscle Cells, Embryonic See Myoblasts

Muscle Cells, Heart See Myocytes, Cardiac

Muscle Cells, Precursor See Myoblasts

Muscle Contraction WE 504

See also Spasm

Muscle Development WE 500

Muscle Diseases, Inflammatory See Myositis

Muscle Disorders See Muscular Diseases

Muscle Dystonia See Dystonia

Muscle Fatigue

General

WE 504

Localized, by site

Muscle Neoplasms WE 550

Muscle Paresis See Paresis

Muscle Protein See Muscle Proteins

Muscle Proteins WE 500

Muscle Relaxants, Central QV 140

Muscle Relaxants, Depolarizing See Neuromuscular Depolarizing Agents

Muscle Relaxants, Non-Depolarizing See Neuromuscular Nondepolarizing Agents

Muscle Relaxants, Polarizing See Neuromuscular Nondepolarizing Agents

Muscle Relaxation WE 504

Muscle Rigidity WE 550

Muscle Spasm See Spasm

Muscle Spasticity WE 550